SERIES C·Nov 10, 2026, 9:11 PM ET·Emerging signal

Ocient raises $100M to expand AI analytics for petabyte-scale data

TL;DR:

  • BOKA Capital and OCA Ventures co-led Ocient's $100 million Series C.
  • Existing investors returned, and Dallas Venture Capital joined as a new backer.
  • Ocient's total funding reached $260 million.
  • Ocient plans to expand delivery of OcientAIQ for organizations working with petabyte-scale data and critical infrastructure.

Summary

Ocient closed a $100 million Series C co-led by BOKA Capital and OCA Ventures. Existing investors returned, while Dallas Venture Capital joined the round. The company will use the financing to expand delivery of OcientAIQ, its agentic AI analytics offering for organizations working with petabyte-scale data and critical infrastructure.

Open businesswire.com in a new tab ↗
Powered by Moatly Lens

The Bigger Picture

The headline tells you what happened. Discover the facts behind it, the forces at work, the connections that matter, and what comes next.

Why This Matters

New funding for Ocient and Zus Health shows investors are betting on startups that handle massive, regulated datasets.

What We Actually Know

  • Zus Health is pursuing a formal role in the national healthcare data-exchange network, though it hasn't been approved yet.
  • Reported, not yet confirmedOcient's total funding now stands at $260 million following its latest round co-led by BOKA Capital and OCA Ventures.

How the Pieces Connect

  • InferenceReported, not yet confirmedWhile Ocient focuses on the sheer volume of data, Zus is navigating the complex regulatory framework of U.S. health data sharing.

What This Could Change

  • ScenarioSecuring QHIN status would give Zus Health a significant competitive moat by making them a central hub for medical records.

Where the Story Goes Next

  • The timeline for Zus Health's final QHIN approval remains uncertain as the candidacy process is ongoing.